Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Weiliang Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0304-0847; OpenAlex author ID A5070646762. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2015: 1 paper · 2016: 3 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 11

  1. Machine learning-Based integration develops a metastasis-Related rhythmic gene signature for improving outcomes in pancreatic cancer. Last author DOI 10.1007/s12672-025-04127-1↗
  2. Machine learning-optimized metabolic biomarker panel for precision screening of early-stage pancreatic cancer in new-onset diabetes. Co-author DOI 10.3389/fendo.2025.1684608↗
  3. Hypoxia-induced circRNF13 promotes the progression and glycolysis of pancreatic cancer. Co-author DOI 10.1038/s12276-022-00877-y↗
  4. GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression. Co-author DOI 10.3389/fcell.2021.640391↗
  5. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Co-author DOI 10.1186/s12943-020-01158-w↗
  6. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. First author DOI 10.4251/wjgo.v11.i8.599↗
  7. Identification of Sox6 as a regulator of pancreatic cancer development. Co-author DOI 10.1111/jcmm.13470↗
  8. The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway. Co-author DOI 10.1016/j.canlet.2015.12.002↗
  9. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer. Co-author DOI 10.1016/j.canlet.2016.04.013↗
  10. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s13046-016-0301-7↗
  11. The inhibitory effects of xanthohumol, a prenylated chalcone derived from hops, on cell growth and tumorigenesis in human pancreatic cancer. Co-author DOI 10.1016/j.biopha.2015.05.020↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rong Wan · 9 shared papers, 2015–2025 · strength 0.84
  2. Zhiyuan Cheng · 2 shared papers, 2025 · strength 0.48
  3. Lijuan Yang · 2 shared papers, 2021–2025 · strength 0.44
  4. Congying Chen · 5 shared papers, 2015–2021 · strength 0.41
  5. Xingya Guo · 3 shared papers, 2019–2022 · strength 0.34
  6. Guoyong Hu · 4 shared papers, 2016–2018 · strength 0.24
  7. Xingpeng Wang · 4 shared papers, 2016–2018 · strength 0.24
  8. Qiuyan Zhao · 2 shared papers, 2019–2022 · strength 0.23
  9. Li Huang · 3 shared papers, 2016–2018 · strength 0.19
  10. Lijuan Yang · 3 shared papers, 2015–2016 · strength 0.15
  11. Zhonglin Zhu · 1 shared paper, 2022 · strength 0.14
  12. Yinshi Huang · 1 shared paper, 2020 · strength 0.11
  13. Kai Li · 1 shared paper, 2020 · strength 0.11
  14. Bin Hu · 2 shared papers, 2016 · strength 0.11
  15. Mingjie Jiang · 1 shared paper, 2019 · strength 0.09
  16. Sisi Li · 1 shared paper, 2019 · strength 0.09
  17. Qiong-Ying Yuan · 1 shared paper, 2018 · strength 0.08
  18. Lijuan Yang · 1 shared paper, 2018 · strength 0.08
  19. Yingying Lu · 1 shared paper, 2015 · strength 0.05
  20. Xiaohua Jiang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.